| Browse All

eXoZymes, Inc. (EXOZ)

Healthcare | Biotechnology | Monrovia, United States | NasdaqCM
10.60 USD +0.10 (0.952%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 11.07 +0.47 (4.434%) ⇧ (April 17, 2026, 4:24 p.m. EDT)

Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 11, 2026, 1:30 p.m. EDT

EXOZ has shown some upward momentum in recent price movements, with a notable increase from around $7.15 to $11.70 over the last two weeks. However, the stock has a low volume and is trading below its 50-day average, indicating potential volatility. The recent news about investor presentations and insider activity may hint at some activity, but the lack of a clear trend and the company's negative earnings and return metrics suggest caution. This is not a strong short-term opportunity, and long-term investment potential is limited due to poor fundamentals and lack of dividend history. Avoid unless there is a significant catalyst.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.219840
AutoTheta0.222587
AutoARIMA0.224570
AutoETS0.248669

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 41%
H-stat 29.13
Ljung-Box p 0.000
Jarque-Bera p 0.098
Excess Kurtosis -1.57
Attribute Value
Sector Healthcare
Debt to Equity Ratio 36.595
Market Cap 89,771,296
Previous Name Invizyne Technologies, Inc.
Website https://www.exozymes.com

Info Dump

Attribute Value
52 Week Change 0.0028653145
Address1 750 Royal Oaks Drive
Address2 Suite 106
All Time High 23.99
All Time Low 7.08
Ask 16.22
Ask Size 1
Average Daily Volume10 Day 10,180
Average Daily Volume3 Month 4,445
Average Volume 4,445
Average Volume10Days 10,180
Bid 10.5
Bid Size 1
Book Value 0.404
City Monrovia
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 10.6
Current Ratio 2.514
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 10.9
Day Low 10.5572
Debt To Equity 36.595
Display Name eXoZymes
Earnings Call Timestamp End 1,747,083,600
Earnings Call Timestamp Start 1,747,083,600
Earnings Timestamp End 1,747,047,540
Earnings Timestamp Start 1,747,047,540
Ebitda -9,428,510
Ebitda Margins 0.0
Enterprise To Ebitda -9.342
Enterprise Value 88,081,208
Eps Trailing Twelve Months -1.09
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 8.84452
Fifty Day Average Change 1.7554808
Fifty Day Average Change Percent 0.19848232
Fifty Two Week Change Percent 0.28653145
Fifty Two Week High 18.4
Fifty Two Week High Change -7.799999
Fifty Two Week High Change Percent -0.423913
Fifty Two Week Low 7.08
Fifty Two Week Low Change 3.5200005
Fifty Two Week Low Change Percent 0.49717522
Fifty Two Week Range 7.08 - 18.4
Financial Currency USD
First Trade Date Milliseconds 1,731,508,200,000
Float Shares 6,319,901
Free Cashflow -3,628,369
Full Exchange Name NasdaqCM
Full Time Employees 32
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.71118
Held Percent Institutions 0.00738
Implied Shares Outstanding 8,468,990
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Long Name eXoZymes, Inc.
Market us_market
Market Cap 89,771,296
Market State CLOSED
Max Age 86,400
Message Board Id finmb_1687004448
Most Recent Quarter 1,767,139,200
Name Change Date 2,026-04-16
Net Income To Common -9,158,734
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 89,771,294
Open 10.9
Operating Cashflow -6,502,040
Operating Margins 0.0
Payout Ratio 0.0
Phone 626 415 1488
Post Market Change 0.4699993
Post Market Change Percent 4.4339557
Post Market Price 11.07
Post Market Time 1,776,457,493
Prev Name Invizyne Technologies, Inc.
Previous Close 10.5
Price Hint 2
Price To Book 26.237623
Profit Margins 0.0
Quick Ratio 2.27
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.10000038
Regular Market Change Percent 0.9523846
Regular Market Day High 10.9
Regular Market Day Low 10.5572
Regular Market Day Range 10.5572 - 10.9
Regular Market Open 10.9
Regular Market Previous Close 10.5
Regular Market Price 10.6
Regular Market Time 1,776,456,000
Regular Market Volume 1,612
Return On Assets -0.63904
Return On Equity -1.3256199
Sand P52 Week Change 0.36506534
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 8,468,990
Shares Percent Shares Out 0.0013
Shares Short 10,666
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 9,714
Short Name eXoZymes Inc.
Short Percent Of Float 0.0026
Short Ratio 2.78
Source Interval 15
State CA
Symbol EXOZ
Total Cash 3,039,343
Total Cash Per Share 0.358
Total Debt 1,243,236
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.09
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 11.25971
Two Hundred Day Average Change -0.65970993
Two Hundred Day Average Change Percent -0.05859031
Type Disp Equity
Volume 1,612
Website https://www.exozymes.com
Zip 91,016